by Maria Dalby: Managing patients with active disease who fail to respond to anti-TNF therapy remains a key unmet need in IBD. Introducing a free paper session on… read more.
by Sanjay Tanday: Advances in diagnostics and therapy means the prospects of living a normal active life free of symptoms and disability are better than ever for IBD… read more.
by Sanjay Tanday: Advances in diagnostics and therapy means the prospects of living a normal active life free of symptoms and disability are better than ever for IBD… read more.
by Maria Dalby: Accurate diagnosis and monitoring are key elements in the prevention of long-term complications of Crohn’s disease including stenosis, strictures and perforation. Rising Star award winner… read more.
by Maria Dalby: Accurate diagnosis and monitoring are key elements in the prevention of long-term complications of Crohn’s disease including stenosis, strictures and perforation. Rising Star award winner… read more.
A faecal microbiota transplant (FMT) not only cured a case of Clostridium difficile (C. diff) infection in a 66 year old man; it eliminated populations of multi-drug resistant organisms both… read more.
In a new paper in the journal Infection and Immunity, the researchers lay out for the first time exactly how C. difficile wreaks havoc on the guts of animals in a… read more.
Cystic fibrosis is a genetic disorder that affects one out of every 3,000 children in populations of Northern European descent. One of the key signs of cystic fibrosis… read more.
by Bruce Sylvester: Treatment of recurrent Clostridium difficile infection with oral, frozen and encapsulated fecal material from unrelated donors has resulted in a 90 percent rate of resolution… read more.
by Bruce Sylvester – New “real world” data suggests that the efficacy of Remsima® (infliximab), a biosimilar monoclonal antibody (mAb) anti-TNF-alpha agent approved by the European Commission, is… read more.
by Bruce Sylvester – Compared to no screening, flexible sigmoidoscopy screening has resulted in a reduced incidence of colorectal cancer and rate of death from colorectal cancer, researchers… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
